Swiss National Bank Biotechnology

Swiss National Bank

$137 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
NUVB Nuvation Bio Inc.	$728M	$750,000 0.0% of portfolio	426,700	Q4 2024 Added 47.09%
CRMD Cor Medix Inc.	$544M	$724,000 0.0% of portfolio	117,600	Q1 2025 New
ALT Altimmune, Inc.	$185M	$697,000 0.0% of portfolio	139,500	Q2 2024 Added 31.6%
ARVN Arvinas, Inc.	$426M	$659,000 0.0% of portfolio	94,000	Q2 2024 Reduced 17.62%
EYPT Eye Point Pharmaceuticals, Inc.	$483M	$609,000 0.0% of portfolio	112,400	Q1 2025 Added 12.4%
RLAY Relay Therapeutics, Inc.	$489M	$594,000 0.0% of portfolio	227,000	Q1 2025 Added 3.37%
KURA Kura Oncology, Inc.	$536M	$589,000 0.0% of portfolio	89,300	Q3 2024 Reduced 8.22%
VERV Verve Therapeutics, Inc.	$667M	$562,000 0.0% of portfolio	123,100	Q1 2025 Reduced 7.51%
CVAC Cure Vac N.V.	$1.01B	$549,000 0.0% of portfolio	198,547	Q4 2023 Reduced 10.32%
ARCT Arcturus Therapeutics Holdings Inc.	$477M	$505,000 0.0% of portfolio	47,700	Q2 2024 Added 1.06%
SVRA Savara Inc	$435M	$493,000 0.0% of portfolio	178,000	Q4 2024 Reduced 6.71%
MRVI Maravai Lifesciences Holdings, Inc.	$350M	$488,000 0.0% of portfolio	221,000	Q4 2023 Reduced 10.34%
CGEM Cullinan Oncology, Inc.	$312M	$474,000 0.0% of portfolio	62,700	Q4 2024 Reduced 14.81%
PHAT Phathom Pharmaceuticals, Inc.	$505M	$459,000 0.0% of portfolio	73,300	Q3 2024 Added 30.89%
ERAS Erasca, Inc.	$197M	$450,000 0.0% of portfolio	328,700	Q1 2025 Reduced 9.0%
STOK Stoke Therapeutics, Inc.	$870M	$447,000 0.0% of portfolio	67,300	Q4 2024 Added 20.39%
PHVS Pharvaris N.V.	$808M	$412,000 0.0% of portfolio	26,257	Q3 2024 New
HUMA Humacyte, Inc.	$155M	$406,000 0.0% of portfolio	237,900	Q1 2025 Added 38.23%
SANA Sana Biotechnology, Inc.	$575M	$399,000 0.0% of portfolio	237,900	Q3 2024 Reduced 8.57%
ORIC Oric Pharmaceuticals, Inc.	$413M	$381,000 0.0% of portfolio	68,400	Q1 2025 Added 9.62%
TRDA Entrada Therapeutics, Inc.	$161M	$296,000 0.0% of portfolio	32,800	Q2 2024 Added 42.61%
TYRA Tyra Biosciences, Inc.	$496M	$273,000 0.0% of portfolio	29,400	Q1 2025 Added 42.03%
ATXS Astria Therapeutics, Inc.	$109M	$262,000 0.0% of portfolio	49,200	Q1 2025 Reduced 26.13%
ANNX Annexon, Inc.	$101M	$260,000 0.0% of portfolio	135,000	Q4 2024 New
PLRX Pliant Therapeutics, Inc.	$85.2M	$129,000 0.0% of portfolio	95,700	Q4 2024 Added 1.59%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	75,700	Q3 2024 Added 14.7%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.